Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67,604,359
-
Total 13F shares
-
49,424,226
-
Share change
-
+2,529,585
-
Total reported value
-
$2,915,087,053
-
Put/Call ratio
-
97%
-
Price per share
-
$58.98
-
Number of holders
-
259
-
Value change
-
+$145,761,689
-
Number of buys
-
131
-
Number of sells
-
118
Institutional Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q3 2019
As of 30 Sep 2019,
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) was held by
259 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,424,226 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, FRED ALGER MANAGEMENT, LLC, FEDERATED INVESTORS INC /PA/, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, TimesSquare Capital Management, LLC, Redmile Group, LLC, and Consonance Capital Management LP.
This page lists
261
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.